HIV-Exposure and Infant Mortality in Botswana

The AIDS epidemic has had a devastating impact on child survival in sub-Saharan Africa. In Botswana, under-five mortality almost doubled from 1990 to 2000. Since then, remarkable progress has been made to prevent pregnant HIV-positive mothers from passing the virus to their infants, either in utero or through breastfeeding. Yet in a study published this July in BMC Pediatrics, Harvard AIDS Initiative (HAI) researchers found that HIV-exposed or infected children in Botswana account for more than half of deaths in children younger than two. Continue reading

Three Words to Describe Ric Marlink?

For almost 30 years, Dr. Richard Marlink helped shape the work of the Harvard AIDS Initiative (HAI). As he leaves to create and lead the Rutgers Global Health Institute, we—his colleagues at HAI— created a short video to express our appreciation of his work and gratitude for his friendship.

The Future of Nigeria’s Response to HIV: Q&A with Dr. Oluwatobi Victor Popoola

Young women in Abuja, Nigeria.

By Belinda O’Donnell

From June to August, I was a peer collaborator for the Mandela Washington Fellows, based at Howard University in Washington D.C. There I met the remarkable Dr. Victor Popoola, an HIV clinician and 2016 Fellow.

Continue reading

The Life and Times of Vin McCarthy

You don’t get much more Boston than Vincent P. McCarthy. Vin grew up in Boston’s Brighton neighborhood in the 1940s and 50s. All four of his grandparents were Irish immigrants. After graduating from Boston College in 1962 and Harvard Law School in 1965, he joined Hale and Dorr, a prominent Boston law firm. “For a peasant, I’ve had a very good life,” jokes McCarthy.

Continue reading

Aldatu Licenses Technology from Harvard

One Step Closer to Affordable HIV DrugResistance Test

Harvard recently entered into a licensing agreement with Aldatu Biosciences for exclusive use of the PANDAA technology. Using PANDAA, Aldatu, a biotech start-up based at LabCentral in Cambridge, is developing a rapid HIV drug-resistance test for patients failing first-line antiretroviral therapy (ART).

Continue reading

The Job of a Lab Manager

A lab manager is responsible for the day-to-day activities of a research laboratory, making sure that the work on the bench and behind the scenes runs smoothly. Click on image to see full infographic.

Lab Manager Job icons


A special thanks to Don Hamel, Lab Manager of the Kanki Lab at the Harvard T. H. Chan School of Public Health

Hope Renewed in Durban

AIDS 2016 Durban, opening session

By Scott Dryden-Peterson

The 2000 International AIDS Conference in Durban was a watershed moment. Prevailing opinion turned from thinking that it was impossible to treat AIDS in Africa to believing that it was impossible and immoral not to try. Nelson Mandela, who had stepped down as president of South Africa in 1999, closed the meeting. “Let us not equivocate. A tragedy of unprecedented proportion is unfolding in Africa,” he said. “Let us combine our efforts to ensure a future for our children. The challenge is no less.”

Continue reading

Botswana Harvard Research at AIDS 2016

Researchers from the Harvard AIDS Initiative and the Botswana Harvard AIDS Institute made significant contributions to the 21st International AIDS Conference (AIDS 2016), held July 18-22, in Durban, South Africa. Here is a list of their presentations:

Continue reading

Florence Revisited: America’s History of HIV Travel Restrictions

Scientists and protesters at 1991 International AIDS Conference in Florence

Over 18,000 people met in Durban, South Africa this July for the 21st International AIDS Conference. We look back to a time 25 years ago, when protesters at the 1991 meeting threatened a boycott because of severe U.S. restrictions for HIV-positive travelers.

The mood in Florence was combative. It was June 1991. Scientists, activists and reporters had gathered in Italy to share the latest findings at the International AIDS Conference. Unfortunately, there were no breakthroughs to announce. Continue reading

Jonathan You: Health Justice and the Importance of Being Heard

Jonathan You at work in the Essex Lab

Teenagers aren’t generally known for their self-awareness and commitment to service. Jonathan You is an exception.

The nineteen-year-old rising junior at Harvard is majoring in Molecular and Cellular Biology with a minor in Global Health and Health Policy. “My academic interest in global health was sparked by Case Studies in Global Health: Biosocial Perspectives, a class that provided me with novel viewpoints on healthcare inequity and social medicine,” he said.

Continue reading